DESVENLAFAXINE SUCCINATE

N/A

Manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

53,036 FDA adverse event reports analyzed

Last updated: 2026-04-14

About DESVENLAFAXINE SUCCINATE

DESVENLAFAXINE SUCCINATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The most commonly reported adverse reactions for DESVENLAFAXINE SUCCINATE include DRUG INEFFECTIVE, NAUSEA, HEADACHE, DIZZINESS, ANXIETY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DESVENLAFAXINE SUCCINATE.

Top Adverse Reactions

DRUG INEFFECTIVE2,675 reports
NAUSEA2,392 reports
HEADACHE1,910 reports
DIZZINESS1,879 reports
ANXIETY1,788 reports
FATIGUE1,648 reports
INSOMNIA1,556 reports
FEELING ABNORMAL1,447 reports
DEPRESSION1,356 reports
DRUG WITHDRAWAL SYNDROME1,050 reports
MALAISE1,034 reports
OFF LABEL USE1,018 reports
CONDITION AGGRAVATED929 reports
DIARRHOEA928 reports
PAIN887 reports
SUICIDAL IDEATION825 reports
VOMITING785 reports
SOMNOLENCE762 reports
HYPERHIDROSIS759 reports
WITHDRAWAL SYNDROME729 reports
WEIGHT INCREASED679 reports
TREMOR664 reports
DYSPNOEA635 reports
CRYING616 reports
ASTHENIA604 reports
PARAESTHESIA575 reports
IRRITABILITY559 reports
WEIGHT DECREASED546 reports
DECREASED APPETITE543 reports
MEDICATION RESIDUE533 reports
CONSTIPATION510 reports
FALL506 reports
BLOOD PRESSURE INCREASED496 reports
HYPERTENSION485 reports
PRURITUS462 reports
ARTHRALGIA461 reports
AGITATION448 reports
DRUG INTERACTION446 reports
NERVOUSNESS437 reports
RASH430 reports
CONFUSIONAL STATE392 reports
MEMORY IMPAIRMENT392 reports
VISION BLURRED391 reports
DRUG HYPERSENSITIVITY374 reports
MIGRAINE361 reports
DRY MOUTH340 reports
PALPITATIONS334 reports
DISTURBANCE IN ATTENTION330 reports
PAIN IN EXTREMITY329 reports
PANIC ATTACK326 reports
DEPRESSED MOOD320 reports
ALOPECIA316 reports
COMPLETED SUICIDE299 reports
OVERDOSE298 reports
PRODUCT DOSE OMISSION ISSUE298 reports
ABDOMINAL PAIN UPPER296 reports
ANGER296 reports
ABDOMINAL DISCOMFORT291 reports
HEART RATE INCREASED284 reports
GAIT DISTURBANCE283 reports
CHEST PAIN277 reports
MUSCLE SPASMS274 reports
HYPOAESTHESIA273 reports
PNEUMONIA271 reports
BACK PAIN270 reports
MYALGIA268 reports
PRODUCT USE IN UNAPPROVED INDICATION266 reports
COUGH264 reports
TOXICITY TO VARIOUS AGENTS264 reports
ABDOMINAL PAIN263 reports
DRUG EFFECT DECREASED253 reports
PYREXIA250 reports
EMOTIONAL DISORDER248 reports
SUICIDE ATTEMPT246 reports
NASOPHARYNGITIS245 reports
RESTLESSNESS244 reports
TINNITUS242 reports
STRESS240 reports
ABNORMAL DREAMS238 reports
SEROTONIN SYNDROME238 reports
NIGHTMARE233 reports
UNEVALUABLE EVENT232 reports
DEATH230 reports
DRUG DOSE OMISSION230 reports
DRUG DEPENDENCE229 reports
URTICARIA229 reports
HYPERSENSITIVITY228 reports
VISUAL IMPAIRMENT225 reports
ILLNESS218 reports
INTENTIONAL PRODUCT MISUSE216 reports
HOT FLUSH215 reports
VERTIGO214 reports
CONTUSION213 reports
COVID 19213 reports
HALLUCINATION209 reports
SINUSITIS208 reports
LOSS OF CONSCIOUSNESS206 reports
AMNESIA205 reports
SLEEP DISORDER205 reports
DYSPEPSIA202 reports

Report Outcomes

Out of 26,263 classified reports for DESVENLAFAXINE SUCCINATE:

Serious 42.4%Non-Serious 57.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female18,113 (76.3%)
Male5,403 (22.8%)
Unknown223 (0.9%)

Reports by Age

Age 59323 reports
Age 52322 reports
Age 50320 reports
Age 60318 reports
Age 54317 reports
Age 63315 reports
Age 55312 reports
Age 53307 reports
Age 62299 reports
Age 51297 reports
Age 56293 reports
Age 57284 reports
Age 58284 reports
Age 61279 reports
Age 48275 reports
Age 47273 reports
Age 64269 reports
Age 45265 reports
Age 40258 reports
Age 65258 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DESVENLAFAXINE SUCCINATE?

This profile reflects 53,036 FDA FAERS reports that mention DESVENLAFAXINE SUCCINATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DESVENLAFAXINE SUCCINATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, NAUSEA, HEADACHE, DIZZINESS, ANXIETY, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DESVENLAFAXINE SUCCINATE?

Labeling and FAERS entries often list Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. in connection with DESVENLAFAXINE SUCCINATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.